It is a great honor for us to be reported by California Life Sciences (CLS) Bulletin MedTech Spotlight as one of 13 companies including Abbot, Johnson & Johnson and so on. This special edition explores medtech innovation, achievement and business operations. Our latest article is named as "How Instant NanoBiosensors Hopes Their Technology Will Lead to Early Diagnosis of Neurological Diseases.” This will also help you understand how the integration of nanotechnology into biosensors could benefit the world by moving bioanalysis from laboratory to analysis point of use.Read the full article: https://www.califesciences.org/cls-bulletin-medtech-spotlight/?utm_campaign=CLS%20Bulletin&utm_content=200734068&utm_medium=social&utm_source=linkedin&hss_channel=lcp-100195
Many thanks to EETimes Asia for the invitation. The article was released today with the title “A new method to advance in the early detection of Alzheimer's disease". In this article, Tony Chung, CEO of Instant NanoBiosenosors, presented how INB’s technology can light up the hope for early detection of Alzheimer’s disease in a promising way.Read the full article: https://www.eetasia.com/a-new-method-to-advance-the-early-detection-of-alzheimers-disease/
INB will be holding a webinar with our Japanese distributor BM Equipment Co., Ltd to talk about epitope binning with FOPPR™. Join us!Epitope binning immunoassays using Fiber Optic Particle Plasmon Resonance (FOPPR™) technology could be deployed in the development of new potential drug candidates. Furthermore, it could accommodate up to four mAbs in one experiment run, enabling this characterization process to be more time- and material-efficient for scientists.This webinar will discusses how FOPPR™ is used to characterize closely related “bins” of mAbs targeting the same epitope of the target protein and how the selection process is used to develop assays. We also are pleased to take AnTaimmuBioMed as a real-world example to share how they use FOPPR™ to develop COVID-19 related therapeutic antibodies and diagnostic tools.Speakers:Tony Chung (CEO @Instant NanoBiosensors)Aileen Sun (Technical Application Scientist @Instant NanoBiosensors)Topic: Epitope Binning: A Critical Step in Antibody DevelopmentDate: 16th Feb. 2022Time: 10:00am JST (GMT+09)Contact mail: hama@bmbio.co.jp, bd@instantnano.comRegister: https://us02web.zoom.us/webinar/register/WN_9wVT3TkUSIC9wjuEeeJH7Q
INB will be part of many conferences, webinars, and workshops in 2022. Join us!
Abcam 與 Merck 精選奈捷生技 FOPPR™ 光纖式偵測技術，偕手打造「快速」篩選與「高靈敏」免疫檢測一站式服務。主講者：藍淑芬，艾博抗台灣市場銷售經理鍾尊智，奈捷生技創辦人暨執行長會議議程：– Abcam 免疫偵測技術的進步– 奈捷生技 FOPPR™ 光纖式技術原理與應用– 快速篩選與高靈敏免疫檢測一站式服務報名連結：https://us02web.zoom.us/webinar/register/WN_Ld21lGiZT9u_c9VD_DTpig
Contact
Us
Share
